News | CT Angiography (CTA) | June 17, 2016

Multi-Society Group Releases CAD-RADS for Standardized Coronary CT Angiography Reporting

System designed to bring uniformity to reporting of stenosis and plaque on coronary CTA

CAD-RADS, coronary CT angiography, CCTA, reporting, SCCT, ACR, NASCI, ACC

A coronary CTA scan from a Philips CT scanner illustrating a curved multiplaner reconstruction showing a large occlusion of the artery.

June 17, 2016 — Three medical professional societies this week jointly released a new reporting system to standardize reporting of patients undergoing coronary computed tomography angiography (coronary CTA). Termed CAD-RADS  (Coronary Artery Disease Reporting and Data System), this system will bring consistency to reporting of coronary CTA diagnostic information for millions of patients worldwide. 

Unlike many other major disease areas, until now no standardized system has existed to classify and report patient data for CT scans of coronary artery disease. CAD-RADS fulfills that long-sought goal of the radiology, cardiology and industry communities.

The suggested CAD-RADS classification is applied on a per-patient basis and represents the highest-grade coronary artery lesion documented by coronary CTA. It ranges from CAD-RADS 0 (zero) for the complete absence of stenosis and plaque to CAD-RADS 5 for the presence of at least one totally occluded coronary artery, and should always be interpreted in conjunction with the impression found in the report. Specific recommendations are provided for further management of patients with stable or acute chest pain based on the CAD-RADS classification.

Ricardo C. Cury, M.D., Miami Cardiac and Vascular Institute, Radiology Associates of South Florida and SCCT past president, led a 17-member multi-disciplinary Expert Consensus Group representing four professional societies: The Society of Cardiovascular Computed Tomography (SCCT, the lead society for CAD-RADS), The American College of Radiology (ACR, co-author), the North American Society for Cardiovascular Imaging (NASCI, co-author) and the American College of Cardiology (ACC, which endorsed this publication). 

 

Watch a video interview with Cury on what CAD-RADS means for cardiology and radiology.

 

Cury noted that "our societies developed CAD-RADS to improve communication of coronary CTA results to referring physicians in a consistent fashion, including considerations for patient management.  Standardized reporting will benefit education, research, peer review and quality assurance and improved quality of care. The teamwork amongst our multi-society, multi-disciplinary writing group was exemplary." 

Cury urges the practice community and industry to become familiar with the CAD-RADS classification and modifiers system. "Today's article is the starting point for a very important process. Next, to promote incorporation of CAD-RADS into daily practice, SCCT will partner with other societies and industry to develop tools for every coronary CTA facility considering adoption of CAD-RADS." 

SCCT President-Elect Leslee J. Shaw, Ph.D. added that the next step will be "development of highly sophisticated decision support tools and registries. CAD-RADS is an important part of our strategic plan to ensure that all patients undergoing CCTA have the highest quality of cardiovascular care."

ACR Chief Executive Officer William T. Thorwarth Jr., M.D., FACR, commented that "The ACR, through our representatives on this important project, was pleased to be a part of this critical effort to enable the standardized reporting and subsequent ongoing evaluation and optimal performance of this valuable examination."

The document was published online in the Journal of Cardiovascular Computed Tomography, the Journal of the American College of Radiology (JACR) and JACC Cardiovascular Imaging

For more information: www.scct.org

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 New studies use SIRD model to forecast COVID-19 spread; examine patient CT scans to correlate clinical features with mortality

Fig 1. A sample scoring on CT images of a 63-year-old woman from mortality group demonstrated a total score of 63. It was calculated as: for upper zone (A), 3 (consolidation) × 3 (50–75% distribution) × 2 (both right and left lungs) + 2 (ground glass opacity) ×1 (< 25% distribution) × 2 (both right and left lungs); for middle zone (B), 3 (consolidation) × 2 (25–50% distribution) × 2 (both right and left lungs) + 2 (ground glass opacity) × 2 (25–50% distribution) × 2 (both right and left lungs); for lower zone (C), 3 (consolidation) × (2 (25–50% distribution of the right lung) + 3 (50–75% distribution of the left lung)) + 2 (ground glass opacity) × (2 (25–50% distribution of the right lung) + 1 (< 25% distribution of the left lung)) Yuan et al, 2020 (CC BY 4.0)

News | Coronavirus (COVID-19) | April 01, 2020
April 1, 2020 — A new study, ...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Company emphasizes faster, more advanced CTs, making imaging easier for COVID-19 patients
News | Computed Tomography (CT) | April 01, 2020
April 1, 2020 — United Imaging, a global leader in advanc
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 A brief article from Henry Ford Health System in Detroit, published today in Radiology, reports on the first presumptive case of COVID-19–associated acute necrotizing hemorrhagic encephalopathy.

A, Image from noncontrast head CT demonstrates symmetric hypoattenuation within the bilateral medial thalami (arrows). B, Axial CT venogram demonstrates patency of the cerebral venous vasculature, including the internal cerebral veins (arrows). C, Coronal reformat of aCT angiogram demonstrates normal appearance of the basilar artery and proximal posterior cerebral arteries. Image courtesy of the Radiological Society of North America (RSNA)

News | Coronavirus (COVID-19) | March 31, 2020
March 31, 2020 — A brief article fr
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)

News | Artificial Intelligence | March 31, 2020
March 31, 2020 — The Intelligent Evalua...
In the light of the coronavirus outbreak, MILabs has enhanced its line of high-performance CT scanners to even better detect the disease #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Computed Tomography (CT) | March 27, 2020
March 27, 2020 — Based on recent scientific research, diagnostic X-ray...
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh